CHARLES SCHWAB INVESTMENT MANAGEMENT INC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,915,324
-9.1%
325,371
+14.1%
0.00%0.0%
Q2 2023$3,207,611
+22.3%
285,121
+25.3%
0.00%0.0%
Q1 2023$2,621,768
-0.8%
227,584
-0.2%
0.00%0.0%
Q4 2022$2,644,166
-6.4%
228,142
+2.6%
0.00%0.0%
Q3 2022$2,825,000
+129.5%
222,434
+24.2%
0.00%
Q2 2022$1,231,000
-33.7%
179,153
-6.9%
0.00%
-100.0%
Q1 2022$1,856,000
-17.2%
192,477
+2.1%
0.00%0.0%
Q4 2021$2,242,000
-25.1%
188,559
+2.4%
0.00%0.0%
Q3 2021$2,992,000
-6.2%
184,183
+21.5%
0.00%0.0%
Q2 2021$3,191,000
+67.7%
151,626
+23.8%
0.00%0.0%
Q1 2021$1,903,000
+10.1%
122,492
+48.9%
0.00%0.0%
Q4 2020$1,728,00082,2760.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders